866089-28-3

Basic information

• Product Name: 2,2-DiMethyl-3,4-dihydro-2H-1,4-benzoxazine, 97%
• Synonyms: 2,2-DiMethyl-3,4-dihydro-2H-1,4-benzoxazine, 97%;2,2-Dimethyl-3,4-dihydro-2H-benzo[b][1,4]oxazine
• CAS NO: 866089-28-3
• Molecular Formula: C10H13NO
• Molecular Weight: 163.21632
• Mol File: 866089-28-3.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,2-DiMethyl-3,4-dihydro-2H-1,4-benzoxazine, 97%(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2-DiMethyl-3,4-dihydro-2H-1,4-benzoxazine, 97%(866089-28-3)
• EPA Substance Registry System: 2,2-DiMethyl-3,4-dihydro-2H-1,4-benzoxazine, 97%(866089-28-3)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 866089-28-3(Hazardous Substances Data)

Usage

Uses

It possess various biological activities.

Upstream product

• 10514-70-2 2,2-dimethyl-2H-1,4-benzoxazine-3-one 
• 95-55-6 2-amino-phenol 
• 129339-29-3 2-bromo-N-(2-hydroxyphenyl)-2-methylpropanamide 

Relevant articles and documents

TRIAZINE DERIVATIVE HAVING EGFR INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF

Disclosed are a triazine derivative having EGFR inhibitory activity, a preparation method therefor and use thereof. In particular, disclosed are an EGFR inhibitor having a structure of formula (I), a preparation method therefor, a pharmaceutical composition containing same, use thereof for preparing the EGFR inhibitor, and use thereof in preparing medicaments for treating and/or preventing cancers, tumors or metastatic diseases at least partially related to insertion, deletion or other mutation of EGFR exon 20, and in particular use thereof in preparing medicaments for treating and/or preventing hyperproliferative diseases and diseases inducing cell death disorders. The definition of each substituent of formula (I) is the same as that in the description.

GLYCOSIDE DERIVATIVE AND USES THEREOF

This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.

GLYCOSIDE DERIVATIVE AND USES THEREOF

This invention relates to compounds represented by formula (I) wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.